ACR CONVERGENCE 2020—Among the many ways in which the COVID-19 pandemic has changed the face of modern medicine is the emergence of multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition that shares many features of Kawasaki disease (KD). With this topic in mind, leading pediatric experts from around the world came together…
Jason Liebowitz, MD, is a rheumatologist with Skylands Medical Group in Rockaway, N.J. He completed his undergraduate studies at Johns Hopkins University, Baltimore, and was inducted into Phi Beta Kappa. He attended Johns Hopkins University School of Medicine and completed his internal medicine residency at Johns Hopkins Bayview Medical Center, where he also served as a chief resident. He completed his rheumatology fellowship at Johns Hopkins University and was nominated for the 2019 Distinguished Fellow Award from the American College of Rheumatology. His research has been published in JAMA Internal Medicine, The Journal of Rheumatology, Arthritis Care and Research, The American Journal of Medicine and Medical Humanities. He is a co-editor of the textbook, Clinical Innovation in Rheumatology: Past, Present, and Future, published in 2022. He greatly enjoys teaching trainees and caring for patients, which he considers a tremendous honor and privilege, and he is grateful to be able to cover medical conferences and contribute articles to The Rheumatologist.
Articles by Jason Liebowitz, MD
Under Pressure: An Update on Pulmonary Hypertension
ACR CONVERGENCE 2020—In patients with connective tissue diseases, such as systemic sclerosis (SSc), pulmonary hypertension (PH) remains one of the leading causes of morbidity and mortality. In her lecture on Friday, Nov. 6, Pulmonary Hypertension: An Update, Mardi Gomberg-Maitland, MD, MSc, professor of medicine and medical director of the Pulmonary Hypertension Program at The George…
The Great Debate: Should Jakinibs Be Used Before Biologics after Methotrexate Failure in RA?
ACR CONVERGENCE 2020—In many ways, the current plethora of treatment options for rheumatoid arthritis patients represents an embarrassment of riches. However, while many therapeutics approved by the U.S. Food & Drug Administration (FDA) are available, knowing the order in which to try these medications with patients can be quite challenging. In The Great Debate, held…
Dendritic Cells as Therapeutics: The New Frontier
Cancer treatments, organ transplants and rheumatologic diseases—dendritic cells are being used throughout medicine to create innovative treatments, according to presenters of a virtual session during the European e-Congress of Rheumatology.
Artificial Intelligence in Medicine: The Future Is Now
Advancements in technology and artificial intelligence designed to aid rheumatologists in diagnosing patients and predicting mortality risk were discussed in depth during a session of the European e-Congress of Rheumatology.
Bloody Important: Atherosclerosis & Thrombotic Disease in Rheumatic Conditions
During the 2020 ACR State-of-the-Art Clinical Symposium, Zoltán Szekanecz, MD, PhD, addressed the risks of vascular disease and how to manage them in patients with rheumatic diseases.
Lessons from Master Clinicians: An Interview with Dr. Ronald Anderson
Rheumatologists who are outstanding clinicians, provide consistently exceptional care to patients and serve as role models for colleagues and trainees are in the spotlight in our Lessons from a Master Clinician series. Here, we offer insights from clinicians who have achieved a level of distinction in the field of rheumatology and who are respected by…
Ultrasound in Rheumatology—Past, Present & Future
For most rheumatologists, the key elements of the physical exam—inspection, palpation, percussion and auscultation—have long been second nature, but a fifth modality has grown in importance with respect to making the correct diagnosis: ultrasound. From evaluating for Doppler signal and additional findings indicative of synovitis to identifying bony erosions, chondrocalcinosis, tophi and other articular and…
A Primer on the Management of Scleroderma Emergencies
Patient with autoimmune disease may experience medical emergencies. Here is an overview of recognition and management of three emergent situations for patients with scleroderma: critical digital ischemia, scleroderma renal crisis and intestinal pseudo-obstruction…
Malignant Complications: Screening for Cancer in Rheumatic Diseases
Cancer and autoimmunity have a complex relationship. In a presentation, Ami Shah, MD, MHS, discussed how to use autoantibodies as tools for cancer risk stratification, how to approach cancer screening in individuals with new-onset disease and more…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 16
- Next Page »